2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rossetti FC et al. | Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. | 2016 | Eur J Pharm Sci | pmid:26657201 |
| Mazzoni S et al. | Cytochrome-c Affects the Monoolein Polymorphism: Consequences for Stability and Loading Efficiency of Drug Delivery Systems. | 2016 | Langmuir | pmid:26710233 |
| Patil SS et al. | Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. | 2016 | Drug Dev Ind Pharm | pmid:26651381 |
| Kolev V et al. | Unit cell structure of water-filled monoolein in inverted hexagonal mesophase in the presence of incorporated tricaprylin and entrapped lysozyme. | 2016 | Eur. Biophys. J. | pmid:26424533 |
| Lopes I et al. | Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells. | 2016 | J Liposome Res | pmid:26340109 |
| Aleandri S et al. | Design of Light-Triggered Lyotropic Liquid Crystal Mesophases and Their Application as Molecular Switches in "On Demand" Release. | 2015 | Langmuir | pmid:26039728 |
| Réeff J et al. | Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. | 2015 | Int J Pharm | pmid:25934426 |
| Borgheti-Cardoso LN et al. | An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. | 2015 | Eur J Pharm Sci | pmid:25917525 |
| Murgia S et al. | Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. | 2015 | Colloids Surf B Biointerfaces | pmid:25829131 |
| Ruocco N et al. | How hydrophobically modified chitosans are stabilized by biocompatible lipid aggregates. | 2015 | J Colloid Interface Sci | pmid:25935287 |